PHYSIOLOGICAL REGULATION AND PATHOLOGICAL DISORDERS OF FIBRINOLYSIS

[1] ALMONDHIRY HAB, 1975, BLOOD, V45, P607

[2] STREPTOKINASE REACTIVITY TEST .1. STANDARDIZATION [J]. THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1963, 9 (1-2): : 175 - &

[3] CONGENITAL DEFICIENCY OF ALPHA-2-PLASMIN INHIBITOR ASSOCIATED WITH SEVERE HEMORRHAGIC TENDENCY [J]. JOURNAL OF CLINICAL INVESTIGATION, 1979, 63 (05) : 877 - 884

[4] GENETIC ABNORMALITIES OF THE FIBRINOLYTIC SYSTEM [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1984, 10 (01) : 42 - 50

[5] THE FIBRIN PLATE METHOD FOR ESTIMATING FIBRINOLYTIC ACTIVITY [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1952, 40 (02) : 346 - 351

[6] TISSUE PLASMINOGEN-ACTIVATOR - CHEMICAL AND PHYSIOLOGICAL-ASPECTS [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1984, 10 (01) : 6 - 17

[7] BOOTH NA, 1983, BLOOD, V61, P267

[8] BROCKWAY WJ, 1971, J BIOL CHEM, V246, P4641

[9] CARRELL N, 1983, BLOOD, V62, P439

[10] FIBRINOLYTIC SYSTEM - BASIC CONSIDERATIONS [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 1979, 21 (04) : 241 - 254

[1] ALMONDHIRY HAB, 1975, BLOOD, V45, P607

[2] STREPTOKINASE REACTIVITY TEST .1. STANDARDIZATION [J]. THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1963, 9 (1-2): : 175 - &

[3] CONGENITAL DEFICIENCY OF ALPHA-2-PLASMIN INHIBITOR ASSOCIATED WITH SEVERE HEMORRHAGIC TENDENCY [J]. JOURNAL OF CLINICAL INVESTIGATION, 1979, 63 (05) : 877 - 884

[4] GENETIC ABNORMALITIES OF THE FIBRINOLYTIC SYSTEM [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1984, 10 (01) : 42 - 50

[5] THE FIBRIN PLATE METHOD FOR ESTIMATING FIBRINOLYTIC ACTIVITY [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1952, 40 (02) : 346 - 351

[6] TISSUE PLASMINOGEN-ACTIVATOR - CHEMICAL AND PHYSIOLOGICAL-ASPECTS [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1984, 10 (01) : 6 - 17

[7] BOOTH NA, 1983, BLOOD, V61, P267

[8] BROCKWAY WJ, 1971, J BIOL CHEM, V246, P4641

[9] CARRELL N, 1983, BLOOD, V62, P439

[10] FIBRINOLYTIC SYSTEM - BASIC CONSIDERATIONS [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 1979, 21 (04) : 241 - 254